HIV Infections: all 4,342 studies

Page 15 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.

• Peer Supported Collaborative Care Mental Health and Substance Use Disorder CareActive, not recruitingNCT04601064Not applicable
• B/F/TAF Ease of Swallowability TrialCompletedNCT04600687Not applicable
• A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in LesothoCompletedNCT04598958Not applicable
• Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.CompletedNCT04594109Not applicable
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected PatientsCompletedNCT04592315Phase 1
• HIV Pre-exposure Prophylaxis Implementation Study in South KoreaStatus unknownNCT04583267Not applicable
• Coronary Artery Disease (CAD) in Patients HIV-infectedStatus unknownNCT04579146
• Community Based Screening for HIV Self Testing in FSW in 23 Priority Districts in IndonesiaStatus unknownNCT04578145Not applicable
• TB-CAPT EXULTANT - HIVCompletedNCT04568967Not applicable
• Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 InfectionStatus unknownNCT04560569Phase 2
• Linking Persons With HIV, Discharged From Jail, With Community CareCompletedNCT04560556
• Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)CompletedNCT04554966Phase 1
• BAPS in Botswana: The Thotloetso TrialCompletedNCT04532970Not applicable
• Optimizing Retention in Care and Adherence to Anti-retroviral Therapy Amongst Adolescents Living With HIV in RwandaCompletedNCT04531605Not applicable
• Viral Load Triggered ART Care in LesothoCompletedNCT04527874Not applicable
• PrEP Intervention for People Who Inject Substances and Use MethamphetamineCompletedNCT04523519Phase 4
• Evaluating an HIV Risk Screening Tool for Orphans and Vulnerable Children in TanzaniaCompletedNCT04517760
• COVID-19 Prevalence in HIV-infected PatientsStatus unknownNCT04515225
• Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV InfectionActive, not recruitingNCT04505501Phase 2
• Tushirikiane HIV-self Testing Intervention With Urban Refugee Youth in Kampala, UgandaCompletedNCT04504097Not applicable
• Testing of a Navigation Intervention for Hepatitis C and HIVTerminatedNCT04499651Not applicable
• Bictegravir/FTC/TAF for the Treatment of Primary HIV InfectionStatus unknownNCT04483674Phase 2
• ANRS 12392 Sanu GundoStatus unknownNCT04482010Not applicable
• MAKASI Intervention for African and Caribbean Migrants' Empowerment in Sexual Health in Paris Greater AreaStatus unknownNCT04468724Not applicable
• Efficacy of Efavirenz 400mg vs. 600mg Combined With Lamivudine and Tenofovir in Treatment Naive HIV InfectionStatus unknownNCT04463784Not applicable
• ARTiBIOME: Observational Study on the Effect of HIV and ART on Gut MicrobiomeCompletedNCT04460924
• Adipose Tissue and Immune Activation in HIVCompletedNCT04439448
• Incentives to Promote Sustained Linkage to HIV CareCompletedNCT04431154Not applicable
• Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy ControlsActive, not recruitingNCT04401917Early Phase 1
• Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using WomenCompletedNCT04396678Not applicable
• Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral TherapyCompletedNCT04385719Phase 2
• Differentiated Service Delivery for Antiretroviral TherapyCompletedNCT04383769
• Social Network Approach for Increasing Testing Coverage Among Men Who Have Sex With MenCompletedNCT04379206
• Adaptation and Evaluation of the PMTCT CSC in Dedza and Ntcheu Districts, MalawiCompletedNCT04372667Not applicable
• COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited SettingsCompletedNCT04371835
• HIV Pre-exposure Prophylaxis Implementation Hong Kong StudyCompletedNCT04367688
• Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive PatientsCompletedNCT04364035Phase 2
• Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral InfectionsCompletedNCT04363411Not applicable
• MISC-CBO in Children Affected by HIV/AIDSCompletedNCT04359043Not applicable
• Pregnancy in Women With HIV InfectionStatus unknownNCT04350554
• MHealth Intervention of HIV and STDs Partner Notification for MSMStatus unknownNCT04349748Not applicable
• Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment InterruptionActive, not recruitingNCT04340596Phase 1
• DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years OldActive, not recruitingNCT04337450Phase 2/3
• HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI ResistanceStatus unknownNCT04334551Phase 4
• Accelerated PrEP Access for Black MSM and TWWithdrawnNCT04329442Not applicable
• Improve Functional Health Status in Minority Women With HIVStatus unknownNCT04315675Not applicable
• Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)WithdrawnNCT04305977Not applicable
• Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive PatientsStatus unknownNCT04303598Phase 3
• Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and YouthCompletedNCT04301154Phase 1
• Gut Microbiota Changes of HIV Patients Before and After One Year of ARTCompletedNCT04297501
• HIV Jail POC-AgAB TestingsCompletedNCT04296331
• The BRIDGES Project: Bridging Resources to Engage Women in Integrated HIV Care and Support ServicesCompletedNCT04295876Not applicable
• Triple vs. Double Therapy in naïves HIV-Infected PatientsStatus unknownNCT04295460Phase 4
• Evaluation of Clinical Impacts and Costs of eHealth in RwandaStatus unknownNCT04283929Not applicable
• Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO TrialCompletedNCT04265950Phase 4
• Navigating Insurance Coverage Expansion (NICE)CompletedNCT04263441Not applicable
• Observational Study for the Evaluation of the Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV ReservoirSuspendedNCT04263207
• Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIVTerminatedNCT04249037Phase 4
• Design and Development of a Mobile App to Improve Adherence to Pre-exposure Prophylaxis in Men Who Have Sex With MenCompletedNCT04248790Not applicable
• Point-of Care Ultrasound for Patients With HIVCompletedNCT04246983Not applicable
• Instacare - Rapid ART Initiation Among Persons With HIV and Out of CareCompletedNCT04240691
• Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV InfectionStatus unknownNCT04240509Phase 4
• Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)TerminatedNCT04240210Phase 4
• Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).Status unknownNCT04225325Phase 4
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected AdultsCompletedNCT04224701Phase 1
• A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1CompletedNCT04223804Phase 1
• Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of PolymedicationStatus unknownNCT04222283Phase 4
• Implementation of Rapid HIV Self-Testing Among MSM ProjectCompletedNCT04219878Not applicable
• NAFLD in HIV-infected PatientsStatus unknownNCT04215926
• Role of PLA2G1B During HIV InfectionStatus unknownNCT04208711Not applicable
• Evaluating the Feasibility of Point of Care Birth Testing in EswatiniCompletedNCT04206878
• Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In ZimbabweCompletedNCT04206241
• Project Jumpstart for Improving PrEP Care of Continuum OutcomesCompletedNCT04201327Not applicable
• Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal IntercourseCompletedNCT04195776Phase 1
• Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious DiarrheaCompletedNCT04192487Phase 4
• Mobile Health Interventions for Medication Adherence Among PLWHWithdrawnNCT04191278Phase 4
• Inflammation and Co-Infections in D²EFTWithdrawnNCT04183738Phase 4
• Comparative Effectiveness of Brief HIV Care CounselingCompletedNCT04180280Not applicable
• Usability Study of IeHS in IndonesiaCompletedNCT04179344
• HUSH Restriction in HIV Infected PatientsStatus unknownNCT04172480
• Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIVCompletedNCT04165200Not applicable
• Workplace-based HIV Self-testing Among Men in Uganda (WISe-Men)Status unknownNCT04164433Not applicable
• Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP ServicesCompletedNCT04155502
• Impart: Provider-Assisted HIV Partner NotificationCompletedNCT04155320Not applicable
• Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIVCompletedNCT04155294
• HIV Reengagement and Assessment Mobile Program (Project RAMP)CompletedNCT04151498Not applicable
• Incidence of HIV Infection in Screening Indian Men Who Have Sex With MenWithdrawnNCT04142385
• AmB Dose for Cryptococcal MeningitisStatus unknownNCT04140461Phase 3
• A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian FederationTerminatedNCT04138199
• Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically SuppressedStatus unknownNCT04132674Phase 4
• Home HIV Testing for Older Adults in South AfricaStatus unknownNCT04131465Not applicable
• Lipid Profile and Diabetes Mellitus in People With HIVCompletedNCT04125784
• POC Strategies to Improve TB Care in Advanced HIV DiseaseCompletedNCT04122404Not applicable
• Swaziland HIV Incidence Measurement Survey 2CompletedNCT04117984
• Project YES! Youth Engaging for SuccessCompletedNCT04115813Not applicable
• Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )CompletedNCT04108728Not applicable
• Using Electronic Medical Record Data to Improve HIV Primary CareCompletedNCT04107233Not applicable
• Integrating PrEP Into Family Planning Services at Title X Clinics in the Southeastern USCompletedNCT04097834
• Transgender Education for Affirmative and Competent HIV and HealthcareCompletedNCT04096053Not applicable
• The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT StudyActive, not recruitingNCT04087239

← HIV Infections overview